10-Q//Quarterly update
NABI BIOPHARMACEUTICALS 10-Q
Accession 0001193125-04-177263
$VXRTCIK 0000072444operating
Filed
Oct 24, 8:00 PM ET
Accepted
Oct 25, 4:48 PM ET
Size
827.1 KB
Accession
0001193125-04-177263
Documents
- 10-Qd10q.htmPrimary
FORM 10-Q
- EX-10.1dex101.htm
CHANGE IN CONTROL
- EX-10.2dex102.htm
EMPLOYMENT AGREEMENT
- EX-10.3dex103.htm
CHANGE IN CONTROL
- EX-10.4dex104.htm
EMPLOYMENT AGREEMENT
- EX-10.5dex105.htm
CHANGE IN CONTROL
- EX-10.6dex106.htm
EMPLOYMENT AGREEMENT
- EX-10.7dex107.htm
CHANGE IN CONTROL
- EX-10.8dex108.htm
EMPLOYMENT AGREEMENT
- EX-10.9dex109.htm
CHANGE IN CONTROL
- EX-10.10dex1010.htm
EMPLOYMENT AGREEMENT
- EX-31.1dex311.htm
RULE 13A-14(A)/15D-14(A) CERTIFICATION
- EX-31.2dex312.htm
RULE 13A-14(A)/15D-14(A) CERTIFICATION
- EX-32dex32.htm
SECTION 1350 CERTIFICATION
Issuer
Vaxart, Inc.
CIK 0000072444
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000072444
Filing Metadata
- Form type
- 10-Q
- Filed
- Oct 24, 8:00 PM ET
- Accepted
- Oct 25, 4:48 PM ET
- Size
- 827.1 KB